Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

Erye Pharma Invests in NeoStem

publication date: Dec 3, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Erye Pharmaceutical Co. Ltd of Suzhou tightened its relationship with NeoStem, Inc. (NYSE Alternext: NBS) when principals of Eyre invested $500,000 in a private market financing of NeoStem. The investors paid $1.25 per unit; each unit includes one share of NeoStem and one warrant to purchase an additional share at $1.75. NeoStem ended the trading session at $.91, lower by one cent. In November, NeoStem agreed to acquire a 51% stake in Eyre Pharma. More details...

Stock Symbol: (OTCBB: CHBP)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners